BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Deals

  Young Innovations Announces Acquisition of Astek Innovations

  Young Innovations, a leading global supplier of dental products, today announced the acquisition of Astek Innovations, Ltd. (“Astek”).

  November 6, 2018

   · 

  2 min read
• Biotech Beach

  Doctor Evidence Conducted Systematic Evidence Review for Leading Cardiology Societies for Bradycardia Guideline Evidence Review and Analyses

  Today, the American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society (HRS) published guidelines on the diagnosis and treatment of bradycardia, an abnormally slow heart rate, along with the supporting systematic review.

  November 6, 2018

   · 

  3 min read
• Business

  Accelerate Diagnostics reports Q3 2018 financial results

  Accelerate Diagnostics, Inc. today announced financial results for the quarter ending September 30, 2018.

  November 6, 2018

   · 

  10 min read
• Business

  Rigel Announces Third Quarter 2018 Financial Results and Provides Company Update

  Reports TAVALISSE™ (fostamatinib disodium hexahydrate) net product sales of $4.9 million

  November 6, 2018

   · 

  14 min read
• BioMidwest

  Express Scripts’ myMatrixx Launches myDataSense Analytics Tool

  myMatrixx®, a leader in pharmacy services for workers’ compensation programs and a subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), announces the release of myDataSenseSM, an innovative and customizable digital analytics tool that will help drive patient safety and savings.

  November 6, 2018

   · 

  2 min read
• Business

  Jazz Pharmaceuticals Announces Third Quarter 2018 Financial Results

  GAAP Diluted EPS of $2.41; Adjusted Diluted EPS of $3.58 Reflects Growth of 11%

  November 6, 2018

   · 

  25 min read
• Biotech Bay

  Exelixis to Present at the Stifel 2018 Healthcare Conference on November 13, 2018

  Presentation to be webcast on www.exelixis.com

  November 6, 2018

   · 

  2 min read
• Business

  Genomic Health Announces Record Revenue and Profit in Third Quarter 2018 Financial Results; Raises Full Year Guidance

  Reported $101M in Revenue and Delivered 23 Percent Growth on a Pre-606 Adjusted Revenue Basis

  November 6, 2018

   · 

  22 min read
• Business

  Aerie Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

  Conference Call and Webcast Today, November 6th, at 5:00 p.m. ET

  November 6, 2018

   · 

  17 min read
• Business

  Corindus Reports Third Quarter 2018 Results

  Advancing Development Programs for Remote Robotics and Neurovascular Applications

  November 6, 2018

   · 

  10 min read